Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults
NCT04843631
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
216
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
BFI-751
DRUG:
EU-STELARA®
DRUG:
US-STELARA®
Sponsor
BioFactura Australia Pty Ltd.
Collaborators
[object Object]